Title: Living with HIV, Dying of TB
1Living with HIV, Dying of TB Intensified TB case
finding among people living with HIV
Adapted from presentation by Colleen
Daniels TB/HIV Advocacy Stop TB Department, WHO
2Outline of presentation
- What is intensified case finding?
- Global implementation of TB case finding
- Challenges
- Conclusions
3Intensified Case Finding (ICF)
- Intensified TB case finding (ICF) is an activity,
recommended by the World Health Organization
(WHO), intended to detect possible TB cases as
early as possible among people living with HIV - Screening for symptoms and signs of TB
- TB treatment
- TB sputum smear
- - IPT
- ICF is the first step towards making a TB
diagnosis.
4Intensified Case Finding (ICF)
- TB control programs generally rely on passive TB
case finding - People living with HIV are at much greater risk
of getting TB and if not treated soon enough,
dying from it - often aggressive cases including hard-to-diagnose
smear-negative or extrapulmonary disease. - ICF consists of using a simple questionnaire
looking for the signs and symptoms of TB.
5Percentage of PLHIV screened for TB in countries
with 80 of the global burden, 2006.
6Proportion of PLHIV screened and diagnosed with
TB in selected countries, 2006
29
8
20
31
7Country Screening Tools
8National screening strategy Kenya
- Symptoms and signs
- Adults (any of)
- 1. Cough (of any duration)?
- 2. Blood stained sputum?
- 3. Night sweats gt2 weeks
- 4. Fever ?
- 5. Weight loss?
- 6. Chest pain?
- 7. Breathlessness?
- 8. Fatigue?
- 9. History of previous TB treatment?
- 10. History of close contact with a person
confirmed to have TB? - 11. Swellings in the neck, armpits or elsewhere?
- 12 Diarrhea for more than two weeks?
- Symptom and signs
- Children (any of)
- 1. Cough (of any duration)?
- 2. Blood stained sputum?
- 3. Night sweats gt2 weeks
- 4. Fever? Of any duration?
- 5. Weight loss?
- 6. Chest pain?
- 7. Fast Breathing?
- 8. Fatigue?
- 9. History of previous TB treatment?
- 10. History of close contact with a person
confirmed to have TB? - 11. Swellings in the neck, armpits or elsewhere?
- 12 Diarrhea for more than 2 weeks?
- 13. Failure to thrive?
9National screening strategy Malawi
- Any of the following
- Cough more than 3wks
- Weight loss
- Fever or night sweats
- Fatigue/tiredness
- Loss of appetite
- Lymph node enlargement
10Screening tools in countries
- Screening tools vary from country to country
- More and more non-specific constitutional
symptoms and signs included in tools - Children are not addressed
- Presence of nationally recommended screening tool
does not always guarantee implementation
11Challenge implementation issues
- Standardised screening tool needed?
- Screening tool that can rule out active TB
disease is needed and how best to link it with
IPT? - Who administers the standard tool and where?
- How often should it be administered?
- Monitoring and evaluation- how should it be
recorded and reported?
12Review of some published evidence of TB screening
strategies
13Kimerling, et.al Cambodia,2002IJTLD 2002
6988994
14Day, et. al. South Africa, 2006IJTLD 2006
10523-529
15Demissie, et.al. EthiopiaWorld Lung Health
Conference 2007 Abstract S11
16Some Notes and Observations from available
evidence
- Sesitivity Ability of the test to accurately
diagnose the presence of disease. - Specificity Ability of the test to accurately
identify all people without the condition - These are both measures of accuracy of a
screening tool to identify a person with TB, the
higher the Sensitivity and Specificity the more
accurate the tool. - The accuracy of screening are generally
inconsistent and dependent what types of
screening questions are asked. Eg the more the
symptoms the greater the chances of detecting
anyone with TB, but also the greater the chances
of wrongly suspecting that people have TB when
they dont. - Chronic cough more than 2 or 3 wks alone looks
insensitive predictor of TB in PLHIV - Role of CXR is not clear and inconsistent
17Living with HIV, Dying of TB Conclusions
- People with HIV have the right to ask for TB
screening and diagnosis. - Check your country's progress in implementing the
12 collaborative activities and engage with the
NTP and NAP to call for scale up (Global TB
Report)
18Conclusions
- Mobilization by civil society urgently needed to
scale up ICF. - Community driven to create demand
- Educate increase literacy in communities and at
health care facilities - Work with joint TB/HIV national mechanisms to
rapidly scale up - Engage in processes such as Global Fund CCMs
- Demand creation
- Myth busting - ensure that arguments about
challenges to implementation are not a barrier
(HIV experience) - Just do it!
19Conclusions
- Massive research efforts to develop the best and
feasible screening tool are urgently needed - "TB dipstick test"- simple and rapid tool is
crucial - Call for investment and increase in laboratory
capacity and call for adequate referral systems - Recording and reporting
20(No Transcript)